Advestra with Novartis on USD 11.0 bn note placement
Advestra advised Swiss pharmaceutical company Novartis on all Swiss aspects of its USD 11.0 billion note placement. The notes in question were issued in seven tranches of which six were fixed rate notes while one tranche were floating rate notes.
The proceeds will be used to refinance the acquisition of Avidity Biosciences.
The Advestra team
The team Advestra team included Annette Weber (pictured left), Thomas Reutter (pictured right) and Valérie Bayard (all capital markets) as well as Céline Martin (tax).
